MedTrace Logo

Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome

NCT02056665 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-10-21

No results posted yet for this study

Summary

RANDOMIZED CLINICAL TRIAL, PLACEBO COMPARED TO EVALUATE THE EFFICACY AND SAFETY OF MINOCYCLINE IN ANGELMAN SYNDROME (A-MANECE STUDY)

Conditions

Interventions

DRUG

MINOCYCLINE

Pill Minocycline 50 mg capsule

DRUG

PLACEBO (for Minocycline)

Pill manufactured to mimic Minocycline 50 mg capsule

Sponsors & Collaborators

  • Puerta de Hierro University Hospital

    lead OTHER

Principal Investigators

  • Belen Ruiz-Antorán · Clinical Pharmacology. Puerta de Hierro University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-09-30
Completion
2014-11-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056665 on ClinicalTrials.gov